Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia

被引:0
作者
Sharon Wu
Yang Du
John Beckford
Houda Alachkar
机构
[1] University of Southern California,School of Pharmacy
来源
Journal of Translational Medicine | / 16卷
关键词
Vimentin; AML; Overall survival; EMT;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 73 条
[21]  
Belousov R(2007)EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities Cancer Epidemiol Biomarkers Prev 20 1211-618
[22]  
Bill K(2003)MLL-AF9 expression in hematopoietic stem cells drives a highly invasive AML expressing EMT-related genes linked to poor outcome Cancer Res 18 606-undefined
[23]  
Luo X(2006)Highly methylated genes in colorectal neoplasia: implications for screening Leukemia undefined undefined-undefined
[24]  
Lazar A(2010)Transactivation of vimentin by beta-catenin in human breast cancer cells Cancer Cell undefined undefined-undefined
[25]  
Dicker A(undefined)Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis undefined undefined undefined-undefined
[26]  
Mills G B(undefined)beta-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells undefined undefined undefined-undefined
[27]  
Hung M-C(undefined)undefined undefined undefined undefined-undefined
[28]  
Lev D(undefined)undefined undefined undefined undefined-undefined
[29]  
Kidd ME(undefined)undefined undefined undefined undefined-undefined
[30]  
Shumaker DK(undefined)undefined undefined undefined undefined-undefined